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The P2X7 receptor is expressed on T cells, however knowledge of its presence and function on human CD4
+
 and 
CD8
+
 subsets is limited. Immunolabeling with an anti-human P2X7 monoclonal antibody and flow cytometry 
demonstrated that P2X7 is present on the cell-surface of peripheral blood CD4
+
 and CD8
+
 T cells. Time-resolved flow 
cytometry demonstrated that extracellular ATP induced ethidium
+
 uptake into both T cell subsets. Flow cytometric 
measurements also demonstrated that ATP induced the rapid loss of CD62L (L-selectin) from CD4
+
 and CD8
+
 T cells. 
ATP-induced ethidium
+
 uptake and CD62L shedding were dramatically impaired in CD4
+
 and CD8
+
 T cells 
homozygous for the Glu496Ala loss-of-function single nucleotide polymorphism in the P2RX7 gene, demonstrating that 
both processes were a result of P2X7 activation. In summary, these results show that both human CD4
+
 and CD8
+
 T 
cells express P2X7 receptors, and that ATP activation of this receptor can lead to the rapid shedding of CD62L from 
these cells. 
Keywords:  T cell; T lymphocyte; purinergic receptor; damage-associated molecular pattern receptor; extracellular ATP; 
CD62L; L-selectin 
Abbreviations: ATP, adenosine 5’-triphosphate; FITC, fluorescein isothiocyanate; IL-6R, interleukin-6 receptor; mAb, 
monoclonal antibody; PE, R-phycoerythrin; SEM, standard error of the mean; SNP, single nucleotide polymorphism   
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Introduction 
CD62L (L-selectin) is a member of the selectin family 
of cell adhesion molecules, and plays important roles in 
the recruitment and migration of leukocytes to lymphoid 
tissues and sites of inflammation 
[1]
. CD62L directs the 
entry of naïve and central memory T cells to lymph nodes 
to promote immune responses 
[2]
. Moreover, CD62L can 
regulate the migration of certain T cell subsets to sites of 
cutaneous inflammation 
[3]
, as well as to nasal- and gut-
associated lymphoid tissues to promote allergy 
[4]
 and 
gastrointestinal inflammation 
[5]
, respectively. The 
expression of CD62L is regulated by a number of 
mechanisms including proteolytic cleavage from the cell 
surface, which can limit T cell migration and activation 
[6]
. However, the signaling mechanisms involved in 
CD62L shedding have not been fully elucidated. 
Extracellular adenosine 5’-triphosphate (ATP) is a 
damage-associated molecular pattern, which mediates its 
effects through the activation of the P2X7 receptor, a 
trimeric ATP-gated cation channel 
[7]
. P2X7 activation by 
extracellular ATP causes the flux of K
+
, Na
+
 and Ca
2+
, as 
well as the uptake of organic cations including ethidium
+
 
[7]
. The relative amount of P2X7 function however varies 
between humans due to a number of single nucleotide 
EXPERT  BRI F REPORT 
 Ronald Sluyter, et al.  
 P2X7-induced CD62L shedding  
 
45 
 
polymorphisms (SNPs) in the P2RX7 gene that code for 
P2X7 variants with a loss or gain of function 
[8]
. One of 
the most common P2X7 SNPs is rs3751143, which codes 
for a glutamic acid to alanine substitution at amino acid 
496 (Glu496Ala) and leads to a near-complete loss of 
receptor function in homozygous dosage 
[9]
. P2X7 is 
present on mononuclear leukocytes including T cells 
from various species 
[10-12]
. P2X7 activation on T cells 
mediates several cell signaling events including the 
shedding of cell-surface CD62L 
[13,14]
. However, 
knowledge about the presence and function of P2X7 on 
human CD4
+
 and CD8
+
 T cells is limited. Using 
peripheral blood lymphocytes from subjects wild-type, 
heterozygous and homozygous for the Glu496Ala SNP, 
the current study aimed to investigate the presence of 
functional P2X7 receptors on human CD4
+
 and CD8
+
 T 
cells, and whether activation of this receptor results in 
CD62L shedding from these T cell subsets. 
Materials and methods 
Lymphocytes. Peripheral blood was collected from 
healthy human volunteers who were previously identified 
as wild-type, heterozygous or homozygous for the 
Glu496Ala SNP in the P2RX7 gene 
[15]
. Peripheral blood 
mononuclear cells were separated by gradient 
centrifugation using Ficoll-Paque PLUS (Amersham 
Biosciences, Uppsala, Sweden) and cultured in RPMI-
1640 medium (Sigma, St. Louis, MO) containing 10% 
foetal calf serum, 1 mM L-glutamine, 0.1 mM non-
essential amino acids, 5.5 x 10
-2
 mM 2-mercaptoethanol, 
Auckland, New Zealand) for 2 hours at 37
o
C and 95% 
air/5% CO2. The non-adherent cells were collected to 
obtain lymphocytes. Blood was collected and used in 
accordance with institutional guidelines and approval 
from the Wentworth Area Health Service (Penrith, 
Australia) and University of Sydney (Sydney, Australia) 
Ethics Committees. 
Immunolabeling and flow cytometry. Fluorescein 
isothiocyanate (FITC)- and R-phycoerythrin (PE)-
conjugated anti-CD4, CD8 and CD62L monoclonal 
antibodies (mAb) were from BD Biosciences (San Diego, 
CA). PE-Cy5-conjugated anti-CD3 mAb was from Dako 
(Carpinteria, CA). FITC-conjugated anti-P2X7 mAb 
(clone L4) was prepared as described 
[11]
. Lymphocytes 
(1x10
6
) were labeled with fluorochrome-conjugated mAb 
in the presence of 10% human AB serum for 20 min and 
washed. CD3
+
CD4
+
 or CD3
+
CD8
+
 cells within the 
lymphocyte gate (gated by forward and side scatter) were 
analysed for P2X7 or CD62L expression using a 
FACSCalibur flow cytometer and Cell Quest software 
(BD Biosciences). 
Measurement of ATP-induced ethidium
+
 uptake. ATP-
induced ethidium
+
 uptake into lymphocytes was 
measured as described 
[16]
bromide (Sigma Chemical Co., St. Louis, MO) was 
added to lymphocytes (2x10
6
/mL), pre-labeled with 
FITC-conjugated anti-CD4 or CD8 mAb, in KCl medium 
(150 mM KCl, 5 mM D-glucose, 0.1% (w/v) bovine 
serum albumin, 10 mM HEPES, pH 7.4) at 37
o
C, 
followed by the addition of 1 mM ATP (Sigma Chemical 
Co.) 40 s later. Data was acquired at 5 s intervals for 
either CD4
+
 or CD8
+
 cells within the lymphocyte gate 
(selected using forward and side scatter) and analysed 
using WinMDI software (version 2.7; 
http://www.scripps.edu). ATP-induced ethidium
+
 uptake 
was quantitated as the difference in arbitrary units of area 
under the uptake curves in the presence and absence of 
ATP during the first 5 min of incubation. 
Measurement of ATP-induced CD62L shedding. ATP-
induced CD62L shedding from lymphocytes was 
measured as described 
[13]
. Lymphocytes (2x10
6
/mL) 
were incubated for up to 15 min in KCl medium at 37
o
C 
in the presence or absence of 0.5 mM ATP with the 
incubations stopped by adding two volumes of cold 
MgCl2
 
medium (145 mM NaCl, 5 mM KCl, 10 mM 
MgCl2, 10 mM HEPES, pH 7.4). Cells were washed and 
the mean fluorescence intensity of CD62L surface 
expression determined by flow cytometry as above. 
Results are presented as the percentage of CD62L 
expression in the presence of ATP compared to CD62L 
expression in the absence of ATP (control). 
Data presentation and statistical analyses. Data is 
expressed as mean and standard error of the mean (SEM). 
Differences between groups were compared by the One-
way ANOVA (using Tukey's multiple comparison test) 
using Prism 5 (GraphPad Software, San Diego, CA) with 
P < 0.05 considered significant. 
Results and discussion 
Labeling of CD4
+
 and CD8
+
 T cells, from normal 
human subjects, with anti-P2X7 mAb showed that both 
cell subtypes expressed P2X7 on the cell surface (Fig. 1). 
Consistent with previous findings for T and B cells 
[9]
 the 
amount of cell-surface P2X7 between either T cell subset 
from subjects wild-type, heterozygous or homozygous for 
the Glu496Ala SNP was similar (Table 1). The amount of 
cell-surface P2X7 between CD4
+
 and CD8
+
 T cells was 
also similar. The similar but low amounts of P2X7 on 
both T cell subsets is consistent with the relatively low 
amount of P2X7 observed previously on CD3
+
 T cells 
[11]
. 
Extracellular ATP induced ethidium
+
 uptake into 
CD4
+
 and CD8
+
 T cells from wild-type subjects with
 Houdek et al.  
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Figure 1. P2X7 is present on human CD4
+
 and CD8
+
 T cells. 
Lymphocytes wild-type, heterozygous or homozygous for the 
Glu496Ala SNP were labeled with FITC-conjugated P2X7 (black 
line) or isotype control (grey line) mAb, PE-conjugated CD4 or CD8 
mAb, and PE-Cy5-conjugated CD3 mAb, and analyzed by flow 
cytometry. Representative data from six (wild-type) or three 
(heterozygous or homozygous) subjects is shown. 
 
mean arbitrary units of uptake (SEM) of 1664 (510) and 
3478 (1263), respectively (n = 6; Fig. 2). ATP also 
induced ethidium
+
 uptake into CD4
+
 and CD8
+
 T cells 
from heterozygous subjects with mean arbitrary units of 
uptake (SEM) of 509 (356) and 1155 (391), respectively 
(n = 3), which on average was one-third lower than that 
observed for wild-type CD4
+
 and CD8
+
 T cells (Fig. 2). 
In contrast, ATP induced only minimal ethidium
+
 uptake 
into CD4
+
 and CD8
+
 T cells from homozygous subjects 
with mean arbitrary units of uptake (SEM) of 47 (23) and 
295 (105), respectively (n = 3; Fig. 2). Comparison of 
CD4
+
 and CD8
+
 T cells showed that ATP-induced 
ethidium
+
 uptake tended to be higher in CD8
+
 T cells 
than in CD4
+
 T cells for each genotype, but this 
difference did not reach statistical significance. However 
comparison between the subsets is complicated by the 
ability to gate only FITC-labeled CD4
+
 or CD8
+
 T cells, 
as ethidium
+
 interferes with the far-red channel and 
 
Figure 2. P2X7 activation mediates ATP-induced ethidium
+
 
uptake into human CD4
+
 and CD8
+
 T cells. Lymphocytes wild-
type, heterozygous or homozygous for the Glu496Ala SNP were pre-
labeled with FITC-conjugated CD4 or CD8 mAb. Cells were 
suspended in KCl medium (37
o
C) and ethidium
+
 was added, 
followed by the addition of 1 mM ATP 40 s later (arrow). Mean 
fluorescence intensity (MFI) of ethidium
+
 uptake was acquired at 5 s 
intervals by flow cytometry. Ethidium
+
 uptake in the absence of ATP 
was minimal and similar between subsets and subjects (results not 
shown). Representative data from six (wild-type) or three 
(heterozygous or homozygous) subjects is shown. 
 
prevented the use of PE-Cy5-conjugated CD3 mAb on 
our single laser flow cytometer. Natural killer cells, 
which have higher P2X7 function than T cells 
[11]
, can 
also express CD8 
[17]
, and thus would have been included 
in the CD8
+
 gate to potentially contribute to the greater 
P2X7 function of CD8
+
 T cells compared to CD4
+
 T 
cells. Nevertheless immunolabeling with an anti-P2X7 
mAb and measurements of ATP-induced ethidium
+
 
uptake demonstrate that both human CD4
+
 and CD8
+
 T 
cells express P2X7. 
Extracellular ATP also induced a rapid loss of CD62L 
from the cell-surface of CD4
+
 and CD8
+
 T cells from 
wild-type subjects in a near-identical and time-dependent 
fashion (Fig. 3). In contrast to ATP-induced ethidium
+
 
uptake (Fig. 2), ATP induced a loss of CD62L from 
CD4
+
 and CD8
+
 T cells from heterozygous subjects that 
was only marginally slower than that observed for wild-
type T cells (Fig. 3). This rate of loss of cell-surface 
CD62L from CD4
+
 and CD8
+
 T cells from subjects of 
either genotype was similar to that previously reported 
for human CD4
+
 T cells 
[18]
, and for human B and T cells 
[13]
. In contrast, the ATP-induced loss of CD62L was 
dramatically impaired from homozygous T cells 
compared to wild-type or heterozygous T cells (Fig. 3). 
Although the shedding of CD62L into the extracellular 
medium was not directly assessed, ELISA measurements 
of soluble CD62L have confirmed that P2X7 activation 
induces the shedding of CD62L from human B cells 
[13]
. 
Collectively, the above data demonstrates that P2X7 
activation induces the rapid shedding of CD62L from 
both human CD4
+
 and CD8
+
 T cells. 
The cell signaling events that mediate P2X7-induced  
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Table 1. P2X7 expression on human CD4+ and CD8+ T cells. 
 CD4+ T cellsa CD8+ T cellsa 
 MFI Percent MFI Percent 
Wild-type 4.9 (0.5) 29.3 (1.4) 4.8 (0.6) 24.4 (1.6) 
Heterozygote 4.0 (1.1) 27.5 (4.8) 4.0 (0.9) 22.5 (4.3) 
Homozygote 4.2 (0.4) 24.1 (2.1) 4.5 (0.6) 22.6 (3.6) 
a
Lymphocytes wild-type, heterozygous or homozygous for the Glu496Ala SNP were labeled with FITC-conjugated 
P2X7 or isotype control mAb, PE-conjugated CD4 or PE-conjugated CD8 mAb, and PE-Cy5-conjugated CD3 mAb. 
The mean fluorescence intensity (MFI) of P2X7 expression or percent of P2X7 positive cells (Percent) was determined 
by flow cytometry. Data is represented as mean (SEM); n = 6 (wild-type) or n = 3 (heterozygous or homozygous) 
subjects. 
 
shedding of CD62L from T cells remain to be 
determined. Human P2X7 activation induces the rapid 
shedding of CD23 and CXCL16 from malignant B cells 
[19-21]
, as well as the shedding of the interleukin-6 
receptor (IL-6R) from human epithelial cells or murine 
fibroblasts co-transfected with human P2X7 and human 
IL-6R 
[22]
. Human P2X7-induced CD23, CXCL16 and 
IL-6R shedding is primarily mediated by ADAM10 
[21,22]
, 
however it is likely that ADAM17 is the principle 
sheddase involved in P2X7-induced CD62L shedding 
from human CD4
+
 and CD8
+
 T cells. It has previously 
been shown that P2X7-induced CD62L and CD23 
shedding from malignant B cells is mediated by different 
metalloproteases 
[20]
, and that ADAM17 is the principle 
sheddase for both calcium- and ATP-induced CD62L 
shedding from murine B cells 
[23]
. Furthermore, P2X7-
induced CD62L shedding from malignant B cells is 
impaired by the zinc-metalloprotease inhibitor, Ro 31-
9790, 
[20]
 which indirectly supports a role for ADAM17 
in this process. 
 
Figure 3. P2X7 activation mediates ATP-induced CD62L 
shedding from human CD4
+
 and CD8
+
 T cells. Lymphocytes wild-
type, heterozygous or homozygous subjects for the Glu496Ala SNP 
were suspended in KCl medium (37
o
C), and incubated for up to 15 
min in the absence or presence of 0.5 mM ATP. Incubations were 
terminated and the expression of CD62L on CD3
+
CD4
+
 and 
CD3
+
CD8
+
 T cells measured by flow cytometry. Results are shown 
as the mean percentage loss of CD62L (SEM); n = 6 (wild-type) or n 
= 3 (heterozygous or homozygous). **P < 0.01 or ***P < 0.001 to 
corresponding wild-type T cells subset. 
Despite the known involvement of ADAM10 and 
ADAM17 in P2X7-induced shedding of cell-surface 
molecules, the cell signaling mechanisms involved in this 
process have remained far more elusive. Attempts using 
inhibitors of candidate enzymes predicted to mediate 
P2X7-induced CD62L and CD23 shedding have failed to 
show a role for various intracellular signaling enzymes 
[13,18,24]
. In contrast, use of 4,4’-diisothiocyanatosilbene-
2,2’-disulphonic acid, an inhibitor of phosphatidylserine 
translocation, indicates that P2X7-induced CD62L 
shedding from murine CD4
+
CD45RB
high
 T cells is 
dependent on phosphatidylserine exposure 
[25]
, although 
the precise mechanism involved in this signaling axis 
remains to be determined. Moreover, mitochondrial but 
not NADPH oxidase superoxide formation has been 
shown to enhance P2X7-induced CD62L shedding from 
human CD4
+
 T cells, but despite this observation P2X7-
induced CD62L shedding appears to be independent of 
mitochondrial superoxide formation 
[18]
. Thus, further 
studies are required to ascertain the cell signaling 
pathways involved in P2X7-induced metalloprotease 
activation and the subsequent shedding of cell-surface 
molecules including CD62L. Further studies are also 
required to determine the physiological significance of 
P2X7-induced CD62L shedding in inflammation. 
In summary, the current results show that both human 
CD4
+
 and CD8
+
 T cells express P2X7, and that activation 
of this receptor by extracellular ATP can lead to the rapid 
shedding of CD62L from these cells. 
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